Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00208949 · ClinicalTrials.gov registry record · Phase 2
A Comparison of Dendritic Cell Content and T-Cell Phenotype Between Granulocyte Colony-Stimulating Factor (G-CSF) or G-CSF + Granulocyte Macrophage (GM)-CSF
A Phase 2 study, sponsored by Emory University.
- Terminated
- Registry status
- Phase 2
- Development phase
- 50
- Enrollment target
NCT00208949 is a Phase 2 study that was terminated before completion, run by Emory University. The registered enrollment target is 50 participants.
The verdict
NCT00208949, a Phase 2 study, was terminated before completion, sponsored by Emory University.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 50 participants
- Enrollment target
Study Summary
This is a study involving patients who are undergoing allogeneic peripheral blood stem cell transplantation. Both donors and recipients are being sought for this study.
Interventions
- DRUG G-CSF
- DRUG GM-CSF
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2002-09 |
| Est. Completion | 2012-05 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00208949
The ClinicalTrials.gov registry entry for NCT00208949 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Emory University, which has 1,208 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which G-CSF is the first listed.
NCT00208949 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00208949 about?
NCT00208949 is a clinical study titled "A Comparison of Dendritic Cell Content and T-Cell Phenotype Between Granulocyte Colony-Stimulating Factor (G-CSF) or G-CSF + Granulocyte Macrophage (GM)-CSF". This is a study involving patients who are undergoing allogeneic peripheral blood stem cell transplantation. Both donors and recipients are being sought for this study.
What is the current status of trial NCT00208949?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 50 participants. The study started on 2002-09. Estimated completion is 2012-05.
What interventions are being tested in trial NCT00208949?
The interventions under investigation include: G-CSF (DRUG), GM-CSF (DRUG).
Who is sponsoring clinical trial NCT00208949?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.